Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin.

C.M. Zwaan, D Reinhardt, H Jurgens, DR Huismans, K. Hahlen, OP Smith, A Biondi, E.R. van Wering, J Feingold, G.J.L. Kaspers

Research output: Contribution to journalArticleAcademicpeer-review

15 Citations (Scopus)
Original languageEnglish
Pages (from-to)468-70
Issue number2
Publication statusPublished - 2003

Cite this